Jump to content

TYK40: Difference between revisions

From PedsAnesthesiaNet
No edit summary
m Text replacement - "<p style="text-align: center;"> About Test Your Knowledge</p>" to "<p style="text-align: center;"> About Test Your Knowledge</p> Category:TYK"
 
Line 24: Line 24:
<p style="text-align: center;">[[TYK39|<Prev Question]] --- [[TYK41|Next Question>]]</p>
<p style="text-align: center;">[[TYK39|<Prev Question]] --- [[TYK41|Next Question>]]</p>
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p>
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p>
[[Category:TYK]]

Latest revision as of 02:31, 25 September 2026

In the infant population, which of the following NMBA is an intermediate acting agent?

A. Atracurium

B. Rocuronium

C. Vecuronium

D. Pancuronium

Click for Answer

Answer

The answer is A. Pancuronium is a long acting agent (>50 mins) in any population. While in adults and children rocuronium and vecuronium are intermediate acting agents (20-50 mins), in the infant population these agents have a consistently prolonged duration of action (making them long acting agents in this population). This is due to a longer residence time and a lower site concentration needed for effect (increased sensitivity) in the infant.

Notes


Keywords



<Prev Question --- Next Question>

About Test Your Knowledge